Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EPH Receptor A3 anticorps (Extracellular, N-Term)

L’anticorps anti-EPH Receptor A3 Polyclonal Lapin est utilisé pour la détection de EPH Receptor A3 dans des échantillons de Humain. Il a été validé pour WB, IHC, IF, FACS et LCI.
N° du produit ABIN7043123
977,85 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 8 à 9 jours ouvrables

Aperçu rapide pour EPH Receptor A3 anticorps (Extracellular, N-Term) (ABIN7043123)

Antigène

Voir toutes EPH Receptor A3 (EPHA3) Anticorps
EPH Receptor A3 (EPHA3)

Reactivité

  • 71
  • 38
  • 37
  • 9
  • 8
  • 5
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Humain

Hôte

  • 74
  • 7
  • 5
  • 1
Lapin

Clonalité

  • 72
  • 15
Polyclonal

Conjugué

  • 47
  • 5
  • 4
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp EPH Receptor A3 est non-conjugé

Application

  • 65
  • 44
  • 26
  • 13
  • 13
  • 11
  • 8
  • 7
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS), Live Cell Imaging (LCI)
  • Épitope

    • 15
    • 13
    • 11
    • 8
    • 8
    • 7
    • 6
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 488-500, Extracellular, N-Term

    Fonction

    A Rabbit Polyclonal Antibody to EphA3 Receptor

     Réactivité croisée

    Humain, Souris, Rat

    Homologie

    Rat,mouse - identical

    Attributs du produit

    Anti-EphA3 (extracellular) Antibody (ABIN7043123, ABIN7044245 and ABIN7044246) is a highly specific antibody directed against an epitope of the human protein. The antibody can be used in western blot, immunohistochemistry and live cell flow cytometry applications. It has been designed to recognize EphA3 from human, rat, and mouse samples.

    Purification

    Affinity purified on immobilized antigen.

    Immunogène

    (C)RARGTNVTISSLK, corresponding to amino acid residues 488-500 of human EphA3

    Isotype

    IgG
  • Indications d'application

    WB: 1:200

    FC: 5 μg per reaction

    ICC: The optimal concentration should be determined by the user

    IHC: 1:200

    IP: The optimal concentration should be determined by the user

    Commentaires

    Negative Control: (ABIN7235282)

    Blocking Peptide: (ABIN7235282)

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

    Concentration

    0.8 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
  • Antigène

    EPH Receptor A3 (EPHA3)

    Autre désignation

    EPHA3

    Sujet

    Synonyms: Ephrin type-A receptor 3, EPH-like kinase 4, EK4, Tyrosine-protein kinase TYRO4

    Description: Eph receptors are the largest family of receptor tyrosine kinases (RTKs). Based on sequence similarity and the type of ephrin ligands that they bind, they are classified into A and B sub-classes. EphA receptors bind ephrin-A ligand while EphB bind ephrin-B ligand.Eph receptors play an important role during embryonic development and are involved in several processes including cell adhesion, cell migration, and tissue boundary formation. Eph receptors are typically expressed at low levels in normal adult tissues1,2.EphA3 (Ephrin type-A receptor 3) structure includes a ligand-binding domain (LBD) at the N-terminus followed by a cysteine-rich region and two fibronectin III repeats. The receptor-binding domain of the ephrins is connected through a short linker segment to a GPI-anchor or a transmembrane segment3.EphA3 was first identified as a surface antigen on pre-B lymphoblastic leukemia cells. High EphA3 levels have been detected in a number of hematological cancers and solid tumors such as lung cancers, melanomas, gastric carcinoma, leukemia, in B and T cell malignancies and in glioblastoma multiforme. In addition, high levels of EphA3 are implicated in lymph node metastasis, advanced stages of colorectal cancer, and prostate cancer1,3,4.

    ID gène

    2042

    NCBI Accession

    NM_005233

    UniProt

    P29320

    Pathways

    Signalisation RTK, Regulation of Cell Size
Vous êtes ici:
Chat with us!